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Nasal and vaginal colonization of methicillin-resistant
Staphylococcus aureus in pregnant women in Cartagena, Colombia
Colonización nasal y vaginal por Staphylococcus aureus resistente a
meticilina en mujeres embarazadas en Cartagena, Colombia
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Summary
Introduction: The host niche for Staphylococcus aureus (SA) are the anterior nares; however, vaginal colonization
rates between 14% and 17.1% in pregnant women have been recently reported, raising interest about the potential
risk in postpartum women and in neonates from colonized mothers.
Objectives: To determine the prevalence of nasal and vaginal colonization of SA and the antibiotic susceptibility
of the isolates in pregnant women attending a maternity hospital in Cartagena, Colombia.
Methods: Nasal and vaginal swabs were obtained from participants and subjected to microbiological and
molecular assays. A post discharge follow-up was performed for up to four weeks.
Results: From 100 pregnant women enrolled in the study, 34 were colonized with SA; 29 only in the nares, three
only in the vagina, and two at both sites. Colonization of pregnant women with SA was more common in the nares
than in the vagina or at both sites [29/34 (85.3%) vs 3/34 (8.8%) and 2/34 (5.9%); p<0.05]. We obtained 36 SA isolates,
nine (25%) of which were methicillin-resistant Staphylococcus aureus (MRSA), one was from the vagina; thus, the overall
MRSA colonization rate among pregnant women was 9%. Molecular analysis showed that Panton-Valentine
leukocidin (PVL) genes were carried by the vaginal MRSA, seven of the nasal MRSA, and two of the Methicillin-
sensitive Staphylococcus aureus (MSSA) isolates. Two MRSA isolates carried SCCmec type I and seven carried
SCCmec type IV.
Conclusions: Nasal colonization rate for SA in the study population was similar to previous reports. However,
the frequency of nasal colonization of MRSA was higher while vaginal colonization of SA was lower than previously
reported in other studies for similar populations. The MRSA isolates obtained showed a community profile.
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Resumen
Introducción: Staphylococcus aureus (SA) ha adoptado como nicho habitual en las narinas anteriores; sin embargo,
recientemente se han reportado tasas de colonización del tracto genital de mujeres embarazadas entre 14% y 17.1%,
lo que aumenta el interés respecto al riesgo asociado para el neonato y la madre en el posparto.
Objetivo: Determinar la prevalencia de colonización nasal y vaginal por SA y los patrones de susceptibilidad a
antibióticos de los aislamientos en una comunidad obstétrica de Cartagena, Colombia.
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Métodos: Se obtuvieron hisopados nasales y vaginales
de las participantes y se sometieron a ensayos
microbiológicos y moleculares. Se realizó seguimiento a
la madre y al neonato durante cuatro semanas.
Resultados: De 100 embarazadas participantes, 34
estuvieron colonizadas con SA; 29 solo en fosas nasales,
tres solo vaginal y dos en ambos sitios. La colonización
fue más común en fosas nasales que en vagina o en ambos
sitios [29/34 (85.3%) vs 3/34 (8.8%) y 2/34 (5.9%);
p<0.05]. Se obtuvieron 36 aislamientos de SA de los
cuales 9 fueron MRSA (25%), proviniendo uno de vagina;
la tasa de colonización total por MRSA en embarazadas
fue 9%. Los genes para la leucocidina de Panton-Valentine
(PVL) se detectaron en la cepa MRSA vaginal, siete
MRSA nasales, y dos MSSA. Dos aislamientos MRSA
portaban el elemento SCCmec tipo I y siete el tipo IV. No
se detectó resistencia a otros antibióticos en los aisla-
mientos MRSA; tres aislamientos susceptibles a meticilina
(MSSA) fueron resistentes a eritromicina.
Conclusiones: Aunque la colonización nasal por SA
en la población estudiada estuvo dentro del rango repor-
tado previamente, la colonización nasal por MRSA fue
mayor, mientras que la colonización vaginal fue más baja
que las informadas previamente en otros estudios para
poblaciones similares. Los aislamientos MRSA obteni-
dos presentaron un perfil comunitario.
Palabras clave: Staphylococcus aureus; Resistencia a
meticilina; Factores de virulencia; Embarazo;
Colonización.
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Staphylococcus aureus (SA) is an important human
pathogen responsible for nosocomial and community-
acquired infections, which also behaves as commensal
flora in healthy individuals – mainly colonizing the
anterior nares1. Carriers of SA, in particular methicillin-
resistant Staphylococcus aureus (MRSA), have a higher
risk for developing clinical infections, being the
infections caused by MRSA strains the most important
at the clinical level because they are more difficult to
treat2. In recent decades, MRSA strains, especially
those associated to the community [community-
associated methicillin-resistant Staphylococcus aureus
(CA-MRSA)] have become an important issue in
public health, given that they are a cause of increased
morbidity and mortality3. These CA-MRSA strains
cause severe skin and soft tissue infections, necrotizing
pneumonia, and sepsis in otherwise healthy children,
teens, and, more recently, in neonates. The increasing
number of infections in neonates caused by CA-
MRSA emphasizes the need to identify the possible
environmentally or maternally derived sources of
infection4,5.
For pregnant women, SA also poses a health risk
because it is the main cause of infection of the
surgical site, causing between 25% and 50% of
infections of the post cesarean surgical site, repre-
senting a major cause of morbidity and a cause of
puerperal mastitis6. Early epidemiological studies
showed that 5% of women were colonized with SA
in their genital tract and postpartum women had the
highest colonization rates; furthermore, vaginal-rec-
tal carriage of SA has been found associated with
development of postpartum fever7. Although risk
factors associated to colonization with MRSA strains
during pregnancy have not been fully characterized,
associations with race, parity, type of birth, and
colonization with group B streptococci have been
suggested7. It is known that incidence of CA-MRSA
infections varies among different communities and
populations, and apparently, pregnant women are
more susceptible and have risk factors that predispose
them to developing these infections6,8. Nevertheless,
there is a scarcity of epidemiologic reports about
MRSA infections present in pregnant and puerperal
women6.
More recently, several studies, mainly from the
United States, have reported vaginal colonization
rates for SA in pregnant women from 14% to 17.1%,
and although the risk of vertical transmission has
been suggested or even demonstrated9-11, the
association of such colonization with infant outcome
has not been clearly established12.
Thus, there is a need to increase knowledge in this
area of research. A literature review of the subject
reveals few published studies in this area, which are
mainly reviews of clinical cases13, making clear that
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more epidemiology-based studies are needed, given
the increasing importance of CA-MRSA strains in
serious neonatal infections14 and in women in
puerperal stage8.
Antibiotic resistance of MRSA strains is due to the
acquisition of mecA gene, which codes for PBP-2a, a
penicillin-binding protein with low binding affinity
for beta-lactam antibiotics. The MecA gene is located
in a mobile genetic element, the chromosomal
staphylococcal cassette (SCCmec) of which seven
major types have been identified, from I to VII.
SCCmec types IV, V and VII are the most frequently
found in CA-MRSA isolates, which also frequently
carry the genes for Panton-Valentine leukocidin
(PVL)15.
Up to 96% of MRSA infections in pregnant
women mainly affect the skin and soft tissue, although
several cases of pneumonia in the puerperal period
have also been attributed to MRSA strains6. Because
PVL-carrying MRSA strains have been implicated in
the development of serious skin and soft tissue
infections and in necrotizing pneumonia16, in the
present study besides determining the SA nasal and
vaginal colonization rates and antibiotic profiles of
the isolates, we evaluated the presence of PVL genes
and SCCmec types of MRSA isolates by multiplex
PCR.
Methods
Design, study population, and inclusion
criteria. This was a pilot study performed by the
Genetics and Molecular Biology Research Group at
Universidad de Cartagena. The study site, the Clínica
de Maternidad Rafael Calvo (CMRC), in Cartagena,
Colombia, is a university-affiliated maternity clinic
attending pregnant women from the urban and rural
areas around Cartagena, and whose obstetric service
delivers between 8,000 and 8,500 infants per year.
Following a research protocol approved by the Ethics
Committee of Universidad de Cartagena and the
Institutional Review Board of CMRC, women with
at least 35 weeks of gestational age, who attended the
outpatient or emergency departments during the
months of January through June 2009 were enrolled
in the study after signing an informed consent. Women
with ruptured membranes and those under antibiotic
treatment or with clinical evidence suggesting a current
staphylococcal infection were excluded from the
study. By following approaches previously described
by Pinter et al.13 and Beigi et al.9 nasal and vaginal swabs
were obtained from the pregnant women enrolled
(n=100) with vaginal samples taken from the outer
third portion of the vagina. Although the objective of
the study was to determine SA nasal and vaginal
colonization rates and antibiotic susceptibility, we
tried to ascertain any possible associations of
colonization with complications related to staphylo-
coccal infection either in the mothers or their
newborns implementing a post discharge weekly
follow-up by telephone for up to four weeks. Mothers
were contacted by telephone at least once a week
during the baby’s first month of life. They were asked
of the general health of their infants, as well as of their
own health. Specific questions were asked to deter-
mine whether any fevers, rashes, or other skin lesions
had occurred in the infant. Additionally, participants
were asked to file a questionnaire about social
demographic data and medical records.
Laboratory methods. Nasal and vaginal
specimens were transported to the microbiology
laboratory of the School of Medicine at Universidad
de Cartagena and processed within 8 to 18 h, according
to protocols described by Bettin et al.17 Antibiotic
susceptibility of isolates confirmed as SA was
performed by the disc diffusion method following
recommendations of the Clinical and Laboratory
Standards Institute (CLSI). The antibiotics evaluated
were: rifampin (5 µg), clindamycin (2 µg), erythromycin
(15 µg), gentamicin (10 µg), vancomycin (30 µg),
cefoxitin (30 µg), and oxacillin (1 µg). The SA strain
ATCC 33591 was used as control. The D-zone test
for inducible clindamycin resistance was performed
for each isolate according to CLSI method. Isolates
were classified as MRSA if they demonstrated
resistance to cefoxitin and MSSA if they were suscep-
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tible. MRSA were further confirmed by PCR
amplification of mecA gene. Both MSSA and MRSA
isolates were stored at -35oC for subsequent molecular
studies.
Molecular analysis
Genomic DNA extraction. Genomic DNA from
each isolate was obtained according to the protocol
described by Millar et al.18 with some modifications.
Briefly, each SA isolate was sub-cultured in nutrient
agar for 24 h at 37oC. Around five colonies were
resuspended in 1 ml of Tris 0.5 M, centrifuged at
13,000 rpm x 5 min. Supernatant was discarded and
the pellet resuspended in 500 µl buffer TE (10 mM
Tris; 1 mM EDTA, pH: 8.0) and boiled at 100ºC for
30 min, and then incubated at -35ºC for 20 min,
thawed at 65ºC and finally centrifuged at 13,000 rpm
for 15 min. Supernatant containing bacterial DNA
was collected in a clean tube and stored at -20ºC for
subsequent PCR assays.
Multiplex PCR assays. Multiplex polymerase chain
reaction assays for assessments of presence of the
lukF-PV (encoding part of the PVL toxin), mecA, and
nuc genes were performed for all SA isolates by using
previously described primers19-21. SA strains ATCC
33591 (mecA+; nuc+; PVL-) and ATCC 25923 (mecA-
; nuc+; PVL+) were used as amplification controls
and pure water as negative controls. All SA isolates
were subjected to multiplex PCR by using a set of
three primer pairs previously reported: MecA1F-
MecA2R that amplifies a 147-bp fragment of mecA
gene; Nuc1F- Nuc2R that amplifies a 300-bp fragment
of nuc gene specific for SA, and LukPV1F- LukPV2R
that amplifies a 437-bp fragment of PVL gene.
Additionally, all confirmed MRSA isolates were
subjected to SCCmec typing by using a multiplex PCR
assay, according to the protocol described by Zhang
et al.19 by using SA strains NCTC10442 for SCCmec
type I, N315 for SCCmec type II, and JCSC4744 for
SCCmec type IV. PCR products were visualized in a
2% agarose gel stained with ethidium bromide under
UV transillumination.
Statistical analysis. Statistical analysis was
performed with SPSS version 13.0 for Windows.
Based on microbiological results, the study population
was classified as carrier and non-carrier and sub-
classified according to the colonization site (vagina/
nares/both) and the frequency of colonization was
determined for each of the two anatomical sites
studied. Univariate analysis was applied to determine
association of colonization to potential risk factors
by using the Fisher exact test using a p value d»0.05
for statistical significance.
Table 1
General demographic characteristics of the
study population (n=100)
Variables   Value
Age (years)
Mean 23.3
SD ± 5
Gestational age (weeks)
Mean 37.7
SD ± 2
Geographical origin
Urban 74
Rural 26
Marital status
Single 13
Married 10
Unmarried partner 77
Schooling
Primary 42
Secondary 22
Technical 21
University 4
None 11
Parity
Nullipara 35
Multipara 65
SD: Standard deviation
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Results and discussion
Table 1 shows demographic data from our study
population and Table 2 shows the general results of
SA isolates from this study. One hundred pregnant
women were enrolled in this pilot study during a 6-
month period and 34 of them were colonized with
SA. Twenty nine of them were colonized only in the
nares, three were colonized only in the vagina, and
two harbored S. aureus at both sites. Colonization of
pregnant women with SA was more common in the
nares than in the vagina or at both sites [29/34
(85.3%) vs 3/34 (8.8%) and 2/34 (5.9%); p<0.05].
From the total of participants, we obtained 36 SA
isolates, nine of which (25%) were MRSA, one was
from the vagina; thus, the overall MRSA colonization
rate among pregnant women was 9%.
The nasal colonization rate for SA found in our
pilot study (29%) was similar to rates previously
reported for the general population2,22. However, the
nasal colonization by MRSA (8% of the overall study
population, 27.6% of the nasal SA isolates) was
higher than the frequencies previously described
both at international and national levels22. Albeit, at
local level there is a report of similar nasal colonization
rates for MRSA in school-age children23; in other
local reports, MRSA nasal isolates were not detected
among elderly individuals residing in a nursing-home17.
To our knowledge, the colonization for SA in pregnant
women had not been evaluated previously in Colom-
bia.
We found in this pilot study 3% vaginal and 2%
nasal and vaginal colonization rates for SA, compara-
ble to rates reported in similar studies in geographically
different populations9,12, and a 29% nasal colonization
rate, which is in the range described in other similar
studies9,13. For MRSA, nasal colonization rates in this
group of pregnant women were much higher (8%)
than the rates reported for the general population15,24
and for pregnant women in different geographical
areas13. For example, a pilot study carried out in
Cleveland (USA) reported that 22% of the study
population were nasal carriers of SA9. The authors of
that study referenced a former report published in
1978 where the nasal colonization of SA in pregnant
women was 4%. In a study similar to ours, Pinter et
al.13, reported that from 304 pregnant women, 34
(11.2%) of them were colonized in the nares, seven
of whom (2.3%) were colonized with MRSA13.
Most recent data on SA colonization in obstetrics
(both MSSA and MRSA) are derived mainly from the
USA5,9-11,13 or Europe12, and until now they provide
little evidence that either universal or targeted
screening is beneficial for mothers or babies5,11,13,24,25.
Higher colonization rates with SA are observed when
the samples are from rectal-vaginal samples10,11
compared to vaginal12,13, which may reflect the fact
that SA colonizes frequently the gastrointestinal tract.
In the study published by Andrews et al.11 genital tract
colonization by MRSA among pregnant women was
evaluated and correlated with infant outcome. From
5732 pregnant women participating in the study, 833
were colonized by SA (14.5%), 202 of whom were
MRSA positive (3.5% overall MRSA colonization).
The authors reported that no cases of early-onset
invasive neonatal infection by MRSA occurred among
infants in their study.
In the pilot study presented here, from 100
pregnant women screened, only five vaginal isolates
were obtained, one of which was MRSA. Social
demographic characteristics of our study population
Table 2
General results for Staphylococcus aureus
isolates (n=36)
Site SA neg SA pos(n=36)
       MSSA1    MRSA2
Nasal 69 23 8
Vaginal 95 2 1
Both3 98 2 0
1.Methicillin-resistant S. aureus
2. Methicillin-sensitive S. aureus
3. Both refers to cases in which S. aureus isolates were
obtained from vagina and nares from the same patient
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are summarized in Table 1. Statistical analysis of this
data did not show significant associations with carrier
state. This may reflect the fact that our sample
population was small, although similar studies with
larger populations have also failed to identify risk
factors for SA colonization in pregnant women and
the implications for maternal and neonatal
outcomes5,11,12. In our study, follow up could only be
completed for 52 mother-infant pairs, and we did not
observe SA-related complications in mothers or in
newborns; thus, we could not identify factors
associated to a higher risk of colonization or
development of complications either in mothers or
infants. To date, rectal vaginal colonization of SA has
been associated to race, parity, route of birth, and
colonization by Streptococcus agalactiae7. In fact, Chen et
al.7, reported that patients colonized by S. agalactiae
were also more likely to be colonized with SA, but
those colonized by MRSA were not colonized with S.
agalactiae.
It is of interest to compare our current results for
maternal colonization with SA and MRSA with those
of Pinter et al.13 who reported a maternal colonization
rate of 14.1% for SA and of 3% for MRSA, much
lower than that reported in the current study. It
should be noted, for comparison, that in the study by
Pinter et al.ref?, all participants delivering their babies
via vaginal route were screened on the day of delivery
at both the nares and the vagina in contrast with the
current study in which pregnant women were screened
at both the nares and vagina between 35 and 42 weeks
of gestational age, 17% of whom were in labor at the
time of sampling. Whether differences in the coloni-
zation rates are related to differences in geographical
areas or in the methodology used remains uncertain.
Although asymptomatic nasal, vaginal, and rectal
colonization with MRSA has been reported to occur
in some pregnancy-related clinical cases in which SA
colonization has been identified as risk factor for
serious systemic infection after delivery8, epidemio-
logical studies show that universal screening and
decolonization efforts in pregnant women are
currently non-cost effective12,25. Similarly, there is no
current evidence that vertical transmission of SA
constitutes a significant risk for neonatal compli-
cations, although vertical transmission of SA have
been documented in some studies4,13.
In our pilot study, antibiotic susceptibility of the
SA isolates found that all MRSA isolates had the
resistance profile associated to the community, with
exclusive resistance to methicillin. Also, three MSSA
isolates had erythromycin resistance; one of them
had the erythromycin inducible clindamycin resistance
phenotype, detected by the D-test. We did not find
resistance to other antibiotics in MRSA or MSSA
isolates.
Table 3 summarizes the characteristics of MRSA
isolates. SCCmec typing by multiplex PCR assay (Fi-
gure 1) showed that among the MRSA isolates from
this study, two had SCCmec type I and seven had
SCCmec type IV, data consistent with community-
associated MRSA, given that it has been previously
reported that MRSA isolates commonly found in
community settings frequently bear SCCmec type IV
(and V)15.
Although controversial, Panton-Valentine leuko-
cidin has been widely regarded as a major virulence
Table 3
Characteristics of methicillin-resistant
Staphylococcus aureus isolates (n=9)
   Characteristics                  Number of isolates
Origin
Nasal
Vaginal 81
PVL1 carrying
Positive
Negative 72
SCCmec2 types
Type I 2
Type IV 7
1 Panton-Valentine Leukocidin
2 Staphylococcal chromosomal cassette mec.
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determinant associated to epidemic clones of CA-
MRSA in the world16. In the current study, we
determined the presence of PVL genes among SA
isolates, both MSSA and MRSA. Among MRSA
isolates, six nasal isolates and the vaginal isolate were
PVL positive (Figure 2). In contrast, among the
MSSA isolates, only two were PVL positive; thus,
PVL genes were more frequently found in MRSA
Figure 1. Multiplex PCR for SCCmec typing. Results for SCCmec typing by multiplex PCR. Lane 1: MW
(DNA molecular weight marker). Lanes 2, 3, and 4 show results for SA strains NCTC10442 (SCCmec type
I), N315 (SCCmec type II), and JCSC4744 (SCCmec IV). Lanes 5 to 13 show SCCmec typing results for MRSA
isolates from the study. Two MRSA isolates were SCCmec type I (Lanes 10 and 11). Seven MRSA isolates
were SCCmec type IV (Lanes 5 to 9 and Lanes 12 and 13). Lane 14 shows the results for a negative control
of the PCR reactions.
Figure 2. Multiplex PCR for detection of nuc, mecA, and PVL genes. Multiplex PCR was carried out to detect
the presence of nuc, mecA, and PVL genes in isolates from pregnant women to confirm Staphylococcus
aureus species (nuc gene), methicillin resistance (mecA gene), and presence of PVL genes. Lanes 1 and
14: M (DNA molecular weight markers). Lanes 2 and 3: ATCC 33591 reference strain (nuc+, mecA+, PVL-
) and ATCC 25923 reference strain (nuc+, mecA-, PVL+), respectively. Lanes 4 to 12: representative
isolates from the study. Lane 13: negative control of the PCR reactions.
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isolates compared to MSSA [7/9 (77.7%) vs 2/27
(7.4%); p<0.01].
Conclusions
Although this was a small pilot study and it may
not be generalized to the entire pregnant population,
the colonization rates found for MRSA were high, as
were the frequency of PVL-positive MRSA isolates,
emphasizing the need for further epidemiologic
studies addressed to evaluate the impact of this
colonization in puerperal and neonatal morbidity in
our geographic region and to identify subpopulations
of pregnant women that may benefit from SA
screening, given that morbidity and associated costs
for MRSA infections in this population are increasingly
reported6,8.
We could not find statistical significance among
socio demographic factors, colonization status, and
development of complications, which could be
attributed to the low number of participants able to
complete the follow up. Thus, additional studies with
more epidemiologic power are needed to ascertain
the role of SA colonization in pregnant women from
our region.
Antibiotic susceptibility profiles, SCCmec typing,
and presence of PVL genes of MRSA isolates points
out to their community origin.
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